1. Home
  2. JBI vs MDXG Comparison

JBI vs MDXG Comparison

Compare JBI & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janus International Group Inc.

JBI

Janus International Group Inc.

HOLD

Current Price

$5.24

Market Cap

987.0M

Sector

Industrials

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$3.62

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBI
MDXG
Founded
2002
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
987.0M
1.0B
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
JBI
MDXG
Price
$5.24
$3.62
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$9.17
$9.00
AVG Volume (30 Days)
1.3M
1.8M
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
0.38
N/A
Revenue
N/A
$418,630,000.00
Revenue This Year
$9.36
N/A
Revenue Next Year
$3.16
$13.02
P/E Ratio
$13.88
N/A
Revenue Growth
N/A
19.99
52 Week Low
$4.75
$3.03
52 Week High
$10.80
$7.99

Technical Indicators

Market Signals
Indicator
JBI
MDXG
Relative Strength Index (RSI) 46.66 47.86
Support Level $5.07 $3.11
Resistance Level $5.76 $7.39
Average True Range (ATR) 0.21 0.18
MACD 0.00 0.07
Stochastic Oscillator 37.76 84.40

Price Performance

Historical Comparison
JBI
MDXG

About JBI Janus International Group Inc.

Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: